comparemela.com

Latest Breaking News On - Glennm chertow - Page 3 : comparemela.com

Research estimates lifetime benefit of combination therapy in patients with kidney disease without diabetes

Research estimates lifetime benefit of combination therapy in patients with kidney disease without diabetes
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United-states
Netherlands
Washington
Groningen
American
Vifor-fesenius
Vifor-fresenius
Boehringer-ingelhiem
Muthiah-vaduganathan
Niels-jongs
Giuseppe-remuzzi
Davidc-wheeler

Reata Pharmaceuticals Announces Presentations at the American Society of Nephrology Kidney Week 2021

Reata Pharmaceuticals Announces Presentations at the American Society of Nephrology Kidney Week 2021
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Japan
Ann-arbor
Michigan
United-states
Missouri
Palo-alto
California
Texas
Stanford-university
University-of-cincinnati
Ohio
San-antonio

Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease

Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease
asnjournals.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from asnjournals.org Daily Mail and Mail on Sunday newspapers.

Mexico
Areata
Coahuila-de-zaragoza
United-states
United-kingdom
London
City-of
Mexican
American
Prolyl-hydroxylase
Vifor-pharma
Bergurv-stef

Dapagliflozin found effective and safe in adults with advanced kidney disease

Dapagliflozin found effective and safe in adults with advanced kidney disease
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

United-states
United-kingdom
Washington
American
Vifor-fresenius
Bergurv-stef
Johnjv-mcmurray
Niels-jongs
Robertd-toto
Eli-lilly
Anna-maria-langkilde
Jose-luis-gorriz

The effects of eliminating race-based adjustments in estimates of kidney function

 E-Mail Washington, DC (May 6, 2021) An ongoing debate is focused on race-based algorithms in medicine such as an adjustment for Black race in equations that estimate individuals kidney function. A study appearing in an upcoming issue of JASN examines the impact of dropping this race adjustment on patient care. Assessing individuals kidney function plays an important role in screening for and treating kidney diseases, and current methods primarily rely on estimating kidney function, what s known as a patient s estimated glomerular filtration rate (eGFR), from the serum creatinine level. The most commonly used eGFR equation includes an adjustment for Black versus non-Black race, resulting in higher eGFR values for a Black patient compared with a non-Black patient. Recognizing that race is a social and not a biological construct, however, several healthcare institutions no longer report eGFR with an adjustment for Black race, and ASN and the National Kidney Foundation have recen

United-states
Washington
American
Mariae-montez-rath
Kurella-tamura
Glennm-chertow
Vishal-duggal
I-chun-thomas
Manjula-kurella-tamura
Nutrition-examination-survey
National-health
Mph-va-palo-alto-health-care-system

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.